Assessment of the Effect of Periodontal Disease Prediction System on Oral Hygiene Motivation

August 27, 2024 updated by: Şadiye GÜNPINAR, Bezmialem Vakif University

Effects of Periodontal Disease Prediction System on Oral Hygiene Motivation in Patients With Periodontitis: A Prospective Randomised Controlled Clinical Study

The aim of this trial is to evaluate the effect of patient specific periodontal disease prediction (PDP) system, a part of motivational interview, (MI) on probing depth (PD), Rustogi modified Navy Plaque Index (RMNPI), and papillary bleeding index (PBI) scores in patients with periodontitis following non-surgical periodontal therapy.

Study Overview

Detailed Description

A total of 120 participants included in our study and were then randomly assigned to three groups: a) conventional method (CM) (n=40), b) three-dimensional animation (3DA) (n=40), and c) Periodontal Disease Prediction (PDP) interaction (n=40). PD, PBI, and RMNPI values were recorded before periodontal therapy (T0). Following periodontal treatment, individuals in the CM group were instructed on oral hygiene via a model and brochure. Individuals in the 3DA group were informed using 3D video visuals. Participants in the PDP group were informed in a computer-based three-dimensional manner, providing projections of their current status and potential future gingival recessions after viewing the first and second parts of the 3D animation. Clinical periodontal measurements were repeated at 3, 6, and 12 months post-treatment. Data obtained after the study were analyzed using appropriate statistical methods. It was concluded that the proposed approach in this project could enhance periodontitis individuals' awareness about periodontal disease and personal oral hygiene especially for interdental cleaning over a long period. By this way, this PDP system can lead clinical benefits in reducing the recurrence of periodontal disease. It was hypothesized that patients in the PDP group could achieve significantly better plaque control and have lower bleeding scores compared to patients in the control groups, which include traditional oral hygiene motivation and three-dimensional video education.

Study Type

Interventional

Enrollment (Actual)

120

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Fatih
      • Istanbul, Fatih, Turkey, 34000
        • Bezmialem Vakıf University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Patients aged 30 to 60 years.
  • No prior periodontal treatment or oral hygiene education.
  • Simplified Oral Hygiene Index (OHI-S) greater than 3 (indicating poor oral hygiene).
  • Diagnosed with 'Stage III' 'Grade B' periodontitis.
  • At least 20 natural teeth present (excluding third molars).
  • Minimum of 12 years of education.
  • Not a dentist or dental student.
  • No systemic diseases affecting memory or cognitive function.
  • No physical disabilities that could hinder the performance of oral hygiene procedures.

Exclusion Criteria:

  • Presence of diffuse dentinal hypersensitivity.
  • Acute infections.
  • Faulty restorations.
  • Root caries complicating oral hygiene.
  • Full-mouth fixed or removable dentures.
  • Ongoing orthodontic treatment.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Conventional Method (CM)
Individuals in this group receive instructions on oral care after initial periodontal treatment from the physician (SG) who is familiar with the patient groups. The physician verbally explains the development of periodontal disease, its causes, symptoms, and the potential consequences of irregular oral care, using a brochure to reinforce these points.
periodontal treatment in all groups was performed using ultrasonic and hand instruments (#15/30, #6/7) by the same physician (UGE) who was blind to the study groups.
Active Comparator: Three-Dimensional Animation (3DA)

The video used in the study was created by DentalMaster (MD Stimulation Ltd) by combining their own footage (http://www.mdsimulation.com/). This video is divided into three parts, summarized below:

  • i. Overview of the causes and symptoms of periodontal disease (section 1)
  • ii. Treatment of periodontal disease and daily oral care practices for individuals (section 2)
  • iii.Consequences of periodontal disease (such as gingival recession and tooth loss) that individuals may face if periodontal diseases are not treated and if they do not perform regular oral care (section 3). In this group, patients watch the video together with the physician (SG), who is familiar with the randomized patient groups.
periodontal treatment in all groups was performed using ultrasonic and hand instruments (#15/30, #6/7) by the same physician (UGE) who was blind to the study groups.

The video used in the study was created by DentalMaster (MD Stimulation Ltd) by combining their own footage (http://www.mdsimulation.com/). This video is divided into three parts, summarized below:

  • i. Overview of the causes and symptoms of periodontal disease (section 1)
  • ii. Treatment of periodontal disease and daily oral care practices for individuals (section 2)
iii.Consequences of periodontal disease (such as gingival recession and tooth loss) that individuals may face if periodontal diseases are not treated and if they do not perform regular oral care (section 3). In this group, patients watch the video together with the physician (SG), who is familiar with the randomized patient groups.
Experimental: Periodontal Disease Prediction (PDP)
The patients in the test group viewed sections 1 and 2 videos in the same manner as the 3DA group. However, unlike the 3DA group, they did not view section 3. Instead, they were shown estimates of their current condition and potential future periodontal tissue loss (gingival recession) for 1-5 years, 5-10 years, and 10-20 years (1). These projections were presented to the patients in three dimensions with PDP visualisation.
periodontal treatment in all groups was performed using ultrasonic and hand instruments (#15/30, #6/7) by the same physician (UGE) who was blind to the study groups.

The video used in the study was created by DentalMaster (MD Stimulation Ltd) by combining their own footage (http://www.mdsimulation.com/). This video is divided into three parts, summarized below:

  • i. Overview of the causes and symptoms of periodontal disease (section 1)
  • ii. Treatment of periodontal disease and daily oral care practices for individuals (section 2)
The patients in the test group viewed sections 1 and 2 videos in the same manner as the 3DA group. However, unlike the 3DA group, they did not view section 3. Instead, they were shown estimates of their current condition and potential future periodontal tissue loss (gingival recession) for 1-5 years, 5-10 years, and 10-20 years. These projections were presented to the patients in three dimensions with PDP visualisation.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
rustogi modified navy plaque index (RMNPI)
Time Frame: baseline (T0) and repeated at 3rd (T1), 6th (T2) and 12th (T3) months
RMNPI was assessed using a specialized plaque staining agent on each of the nine sites on both buccal and lingual tooth surfaces. The individual mean PI was calculated by scoring the presence of plaque at each site as '1' and its absence as '0', then dividing by the total number of surfaces evaluated. Using this index, PI can be separately calculated for the entire mouth (A-I), the gingival margin (A-C), interproximal areas (D and F), and surfaces that come into contact with dental floss (A, C, D, and F)
baseline (T0) and repeated at 3rd (T1), 6th (T2) and 12th (T3) months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Probing depth (PD)
Time Frame: baseline (T0) and repeated at 3rd (T1), 6th (T2) and 12th (T3) months
PD measurements was evaluated at six regions of each tooth
baseline (T0) and repeated at 3rd (T1), 6th (T2) and 12th (T3) months
bleeding on probing (BoP)
Time Frame: baseline (T0) and repeated at 3rd (T1), 6th (T2) and 12th (T3) months
BoP associated with PD measurements was evaluated at six regions of each tooth as presence/absence and recorded as %.
baseline (T0) and repeated at 3rd (T1), 6th (T2) and 12th (T3) months
papillary bleeding index (PBI)
Time Frame: baseline (T0) and repeated at 3rd (T1), 6th (T2) and 12th (T3) months
PBI is calculated by scoring the papillae in the facial/buccal and palatinal/lingual regions of each tooth based on the presence or absence of bleeding from probing and the overall condition of the gingiva. The average PBI value for an individual was calculated by dividing the total sum of the values by the number of papillae assessed.
baseline (T0) and repeated at 3rd (T1), 6th (T2) and 12th (T3) months
Gingival ındex (GI)
Time Frame: baseline (T0) and repeated at 3rd (T1), 6th (T2) and 12th (T3) months
Each tooth's mesial, distal, buccal, and lingual gingival margins are evaluated. These values are then summed and divided by four. This process calculates the Gingival Index (GI) for each tooth. When the total of these values is divided by the number of teeth, the individual's GI score is obtained.
baseline (T0) and repeated at 3rd (T1), 6th (T2) and 12th (T3) months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Sadiye Gunpinar, Asc. Prof., Bezmialem Vakif University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 1, 2021

Primary Completion (Actual)

July 24, 2023

Study Completion (Actual)

July 24, 2023

Study Registration Dates

First Submitted

August 27, 2024

First Submitted That Met QC Criteria

August 27, 2024

First Posted (Actual)

August 29, 2024

Study Record Updates

Last Update Posted (Actual)

August 29, 2024

Last Update Submitted That Met QC Criteria

August 27, 2024

Last Verified

August 1, 2024

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Periodontal Diseases

Clinical Trials on scaling root planing

Subscribe